Medical Weight Loss for Mason City, Iowa Residents

Mason City, Iowa residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Mason City through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Flexible payment for Mason City residents: we accept HSA, FSA, Klarna, and Affirm, so paying for your Iowa telehealth program can fit your budget. Medication is billed separately. Doctor review just $119 (medication separate).

Why Mason City Residents Choose New Hope Weight Loss

New Hope keeps the money part simple so you can focus on the health part. For Mason City patients that means semaglutide from $166 monthly, tirzepatide from $233 monthly, a $119 physician visit, no insurance required, and no penalty for living outside Costa Mesa. We take HSA, FSA, Klarna, and Affirm, so paying out of pocket does not have to mean paying all at once. Clear terms, no games.

Mason City is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

New Hope Weight Loss is based in Costa Mesa, yet a patient in Mason City sees the same doctor, takes the same approach, and pays the same prices, all through telehealth across Iowa. We care for patients throughout downtown Mason City and the greater Cerro Gordo County area of north-central Iowa. Refills are tracked for you and reshipped on schedule, so nothing lapses while you are busy living your life in Mason City.

Wherever you are in Mason City or the wider Iowa area, the program reaches you the same way, with HSA, FSA, Klarna, and Affirm all accepted. Compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and for Mason City patients it starts at $166 per month, billed separately. Wherever you are in Iowa, New Hope Weight Loss delivers physician-supervised GLP-1 programs by secure telehealth from our Costa Mesa, California clinic, with no office visit required.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset, from $166/mo

Most Mason City patients start here. Semaglutide shares its active ingredient with Wegovy and Ozempic, and in branded-drug trials people lost an average of 15 to 17 percent of body weight. Our program runs $499 for 90 days, with Dr. Sharma adjusting your dose each month by telehealth. Results vary, and compounded semaglutide is not FDA-approved or brand-identical.

Tirzepatide, from $233/mo

Tirzepatide works on two hunger pathways at once, GLP-1 and GIP. In trials of the branded drug, qualified patients reached up to 22.5 percent body-weight loss, which is a high-dose figure and not typical. It shares its active ingredient with Mounjaro and Zepbound.

$119 physician review. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, with no surcharge for treating you in Mason City by telehealth.

How Telehealth Works for Mason City

Here is how the whole thing works, start to finish, for anyone in Mason City.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Mason City address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Mason City

Does New Hope Weight Loss actually serve Mason City, or only Costa Mesa?

We serve both. Our single physical location sits in Costa Mesa, California, and we extend care to Mason City, Iowa through telehealth. Residents across neighborhoods like downtown Mason City and the greater Cerro Gordo County area of north-central Iowa qualify the same way. Dr. Anjmun Sharma evaluates whether a compounded GLP-1 plan fits you during your initial video appointment.

Can the whole process be done remotely from Mason City?

Yes, it is fully remote. There is no in-person requirement for Mason City patients at any stage. You meet Dr. Sharma over video, complete intake online, and receive ongoing support by message. Approved prescriptions arrive at your door in insulated cold-pack shipping that protects the medication during delivery.

How much will a Mason City patient pay?

Plan on $119 for the physician visit. Semaglutide runs from $166 monthly, with a $499 option for 90 days, and tirzepatide from $233 monthly. The medication cost is separate from the visit. HSA, FSA, Klarna, and Affirm are all welcome, and Mason City residents pay no added distance fee.

What areas of Mason City do you serve?

We serve patients from across Mason City by telehealth, including downtown Mason City and the greater Cerro Gordo County area of north-central Iowa.

How does compounded medication compare on cost for Mason City patients?

Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Mason City patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.

Mason City Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Mason City, Iowa by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.